Alma Harmony (2023 gen)
Combination Platform · Refreshed multi-module platform
The Alma Harmony (2023 gen) typically sells new in the $100k–$140k range in the US. Alma Harmony (2023 gen)'s FDA status is under verification by our research team. Figures are market estimates verified August 6, 2026.
Last verified: August 6, 2026 · How we verify
New: $100k–$140k|Used: —market estimate, no email required
| Manufacturer | Alma |
|---|---|
| Company | Owner: Sisram Medical Ltd (HKEx: 1696), controlled by Shanghai Fosun Pharmaceutical (subsidiary, since 2013) · Distribution: direct |
| Category | Resurfacing, Tattoo & Vascular |
| Technology | Refreshed multi-module platform |
| FDA status | FDA status under verification |
| New price range | $100k–$140k |
| Used price range | Not published |
| Consumables | Not published |
| Launch year | 2023 |
| Last verified | August 6, 2026 |
Overview
Latest Harmony generation
FDA & regulatory status
FDA status under verification — see our FDA guide. We do not publish an indication or a clearance number for this profile until the record is confirmed against the FDA database.
Regulatory data is compiled from public FDA 510(k) records and may lag recent clearances. Always confirm status with the manufacturer before purchase.
Treatment economics
Economics data for this platform hasn't been published yet.
Chains using this device
No confirmed chain deployments recorded yet.
Owner reviews
Write a reviewNo verified reviews yet — be the first. Founding reviewers get a thank-you gift card for an honest review, positive or negative. How verification works.
Alternatives
History
Every tracked change to pricing, lifecycle status, FDA data and warranty terms — newest first.
August 1, 2026
Record created
Added to The Aesthetic Index — August 2026
Source: The Aesthetic Index editorial
Get the full State of Aesthetic Devices 2026 report
The first full census of the US aesthetic device market — preview it free.